Patenting Biological Simulations in Drug Discovery

 

Our article ‘Patenting Biological Simulations in Drug Discovery’ has been published in Drug Discovery Today, by Elsevier. It examines the challenges faced when pursuing patent protection for biological simulations, particularly in view of the guidance provided by the European Patent Office in G1/19.

Article Highlights:

  • Biological simulations typically require a real world impact to be patentable.
  • Discoveries found using simulations may be patentable in their own right.
  • Substantial and convincing evidence may be required for simulations to be patentable.

Elsevier publish articles for scientific, technical, and medical research in the Physical Sciences and Engineering, Life Sciences, Health Sciences, Social Sciences and Humanities fields.

 

Get in touch

If you are an ambitious business and you expect an IP service provider that can understand and help you achieve your commercial objectives, then we want to work with you. Complete the enquiry form below and one of our specialists will be in touch within one working day. Alternatively you can call us on +44 (0)20 7655 8500. We look forward to hearing from you.